Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

More clinical trials are needed to confirm if plant-based products can effectively treat COVID-19.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

Early diagnosis and personalized treatment are crucial for managing different types of alopecia effectively.

Infrared radiation can cause skin aging and cancer at high temperatures but may have therapeutic benefits at controlled levels.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Future acne treatments should aggressively target inflammation to prevent scarring.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Ongoing research and innovation are crucial for improving skin care and treatment.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Retinoids and narrowband UVB phototherapy are effective for treating psoriasis and can reduce treatment time when used together.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

Semaglutide may help some skin disorders but can also cause skin issues.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Regenerative medicine shows promise for aesthetic surgery, but needs more research for widespread use.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.